Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year

The drug makers Regeneron Pharmaceuticals and Sanofi made a rare move, negotiating with insurers in advance over the price for Dupixent.

Source: NYT Health - March 28, 2017 Category: Consumer Health News Authors: KATIE THOMAS Tags: Drugs (Pharmaceuticals) Eczema Food and Drug Administration Regeneron Pharmaceuticals Inc Sanofi SA Source Type: news